Nucleic Extraction Instruments

The Florida Department of Health, Bureau of Public Health Laboratories (BPHL) is seeking to purchase three MagNa Pure 24 nucleic acid extraction instruments from Roche Diagnostics Corporation. The BPHL requires these instruments to replace its existing Roche MagNA Pure LC 2.0 and MagNA Pure Compact instruments, which are used for public health emergency preparedness activities, including pandemic influenza and Laboratory Response Network methods for detecting bioterrorism threat agents and emerging infectious diseases. The MagNa Pure 24 instruments must be validated and approved by the Centers for Disease Control and Prevention, and have the capability to extract up to 24 samples within a 4-6 hour turnaround time, meeting the quick response requirements of the Public Health Laboratory Response Network. The Department of Health is requesting authorization to purchase the instruments as a single source, as Roche Diagnostics is the exclusive manufacturer and distributor of the MagNa Pure 24 instrument. The estimated dollar amount for the purchase is $150,000, and the deadline for responses is March 24, 2022.

The procurement is open to all interested and qualified vendors, as there are no set-aside designations or restrictions on the types of organizations that can respond. There is no information provided regarding any incumbent vendors or current contractors, or any existing infrastructure or technology that requires integration. The opportunity is limited to the purchase of the three MagNa Pure 24 instruments, and no additional budget ranges or award values are specified.